产品进同仁、合作落日本，这家苏州企业获元禾璞华A+轮投资

Core Viewpoint - Yaoshi Medical has successfully completed A+ round financing, which will primarily be used to accelerate the research and production of ophthalmic medical device equipment [1] Group 1: Company Overview - Yaoshi Medical, established on January 8, 2020, integrates research and development, production, marketing services, and AI big data research in the ophthalmic medical device sector [3] - The founder, Wu Haizhou, has over 15 years of experience in the medical device field and has held technical executive positions in several Fortune 500 companies [3] - The company has built a research team that combines Chinese and Japanese technical experts, with core members having extensive experience in leading Japanese ophthalmic device companies [3] Group 2: Product Development - Yaoshi Medical addresses the limitations of traditional fundus cameras by developing the ultra-wide-angle confocal laser scanning fundus camera (SLO) [4] - The first ultra-wide-angle laser scanning fundus camera is expected to receive national Class II medical device registration by July 2024, with performance indicators meeting or exceeding those of imported products [4] - The device can capture a retinal range of 168 degrees in a single scan, significantly increasing the doctor's field of view and reducing the rate of missed diagnoses [4] Group 3: Strategic Partnerships and Global Expansion - In December 2020, the company established a strategic partnership with a well-known Japanese listed technology company to jointly develop the domestic and international ophthalmic market [6] - In November 2021, a product sales framework agreement was signed with one of Japan's top three ophthalmic groups, further validating the company's product technology and laying the groundwork for international expansion [6]